Tiracizine disposition in healthy volunteers with reference to the debrisoquine oxidation phenotype.

Documenti analoghi

• Debrisoquine oxidation phenotype and susceptibility to lung cancer.
  di: Boobis, A R, et al.
  Pubblicazione: (1990)
• Genetically determined oxidation capacity and the disposition of debrisoquine.
  di: Sloan, T P, et al.
  Pubblicazione: (1983)
• The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine.
  di: Ashforth, E I, et al.
  Pubblicazione: (1994)
• Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype.
  di: Gross, A S, et al.
  Pubblicazione: (1989)
• Disposition of Intravenous Pyrimethamine in Healthy Volunteers
  di: Almond, D. S., et al.
  Pubblicazione: (2000)